Instil Bio, Inc.
TIL
$15.46
$0.1551.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.22% | -10.33% | -7.05% | -6.04% | -28.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.28% | -44.85% | -31.79% | -41.93% | -55.52% |
| Operating Income | 5.28% | 44.85% | 31.79% | 41.93% | 55.52% |
| Income Before Tax | 7.97% | 65.86% | 20.07% | 57.42% | 76.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.97% | 65.86% | 20.07% | 57.42% | 76.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.97% | 65.86% | 20.07% | 57.42% | 76.00% |
| EBIT | 5.28% | 44.85% | 31.79% | 41.93% | 55.52% |
| EBITDA | 3.70% | 46.78% | 33.36% | 41.81% | 55.82% |
| EPS Basic | 8.28% | 65.86% | 20.07% | 57.42% | 76.03% |
| Normalized Basic EPS | 4.57% | 49.61% | 18.38% | 38.41% | 52.81% |
| EPS Diluted | 8.28% | 65.86% | 20.09% | 57.42% | 76.03% |
| Normalized Diluted EPS | 4.57% | 49.61% | 18.38% | 38.41% | 52.81% |
| Average Basic Shares Outstanding | 0.34% | 0.01% | 0.00% | 0.00% | 0.16% |
| Average Diluted Shares Outstanding | 0.34% | 0.01% | 0.00% | 0.00% | 0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |